We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

88 hedge funds and large institutions have $228M invested in ChemoCentryx, Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

32% more capital invested

Capital invested by funds: $173M → $228M (+$55.4M)

5% more funds holding

Funds holding: 8488 (+4)

7% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 29

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $103K

Holders
88
Holders Change
+4
Holders Change %
+4.76%
% of All Funds
2.19%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
31
Reduced
29
Closed
7
Calls
Puts
$103K
Net Calls
-$103K
Net Calls Change
-$14K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1.09M -$53.6K -7,306 -6%
Federated Hermes
27
Federated Hermes
Pennsylvania
$1.04M +$47K +6,399 +6%
Invesco
28
Invesco
Georgia
$1.04M -$986K -134,356 -55%
TCIM
29
TIAA CREF Investment Management
New York
$1.03M -$136K -18,538 -14%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$998K -$7.41K -1,010 -0.9%
BIM
31
Bogle Investment Management
Massachusetts
$888K +$174K +23,755 +33%
Connor, Clark & Lunn Investment Management (CC&L)
32
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$806K +$122K +16,625 +24%
BTS
33
BB&T Securities
Virginia
$781K +$613K +83,500 New
SO
34
STRS Ohio
Ohio
$706K +$168K +22,900 +44%
ADEF
35
Adams Diversified Equity Fund
Maryland
$696K -$99.1K -13,500 -15%
Goldman Sachs
36
Goldman Sachs
New York
$687K -$43.4K -5,915 -7%
Ohio Public Employees Retirement System (OPERS)
37
Ohio Public Employees Retirement System (OPERS)
Ohio
$652K
Thrivent Financial for Lutherans
38
Thrivent Financial for Lutherans
Minnesota
$625K -$369K -50,290 -43%
TC
39
TFS Capital
Pennsylvania
$614K +$481K +65,553 New
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$588K
EGA
41
Eagle Global Advisors
Texas
$586K +$120K +16,310 +35%
Charles Schwab
42
Charles Schwab
California
$542K +$189K +25,800 +81%
PCM
43
Piermont Capital Management
Missouri
$528K -$74.2K -10,110 -15%
KeyBank National Association
44
KeyBank National Association
Ohio
$515K
BPC
45
Banque Pictet & Cie
Switzerland
$507K
BCM
46
Bridgeway Capital Management
Texas
$490K -$184K -25,000 -32%
BBA
47
Baker Bros. Advisors
New York
$459K
Bank of America
48
Bank of America
North Carolina
$429K -$494K -67,253 -59%
WCM
49
Wedge Capital Management
North Carolina
$424K +$333K +45,300 New
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$405K -$22K -3,000 -6%

CCXI Hedge Fund Activity: Q2 2017 in Review

88 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2017, worth a combined $228M — up 32% from $173M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CCXI positions and 7 closed out — a net gain of 4 holders — while 31 added to existing stakes and 29 trimmed.

The largest buyer was BVF Inc, adding an estimated $1.89M. The largest seller was Invesco, cutting an estimated $986K.

  • 88 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2017, up from 84 in Q1 2017.
  • Funds reported $228M of ChemoCentryx, Inc. stock for Q2 2017, up 32% quarter-over-quarter.
  • 11 funds opened new ChemoCentryx, Inc. positions in Q2 2017 and 7 closed out, a net change of +4 holders.
  • The largest ChemoCentryx, Inc. buyer in Q2 2017 was BVF Inc, an estimated $1.89M added.
  • The largest ChemoCentryx, Inc. seller in Q2 2017 was Invesco, an estimated $986K sold.

Based on aggregated 13F filings for Q2 2017.